Nonadherence among HIV-Infected injecting drug users: The impact of social instability

被引:108
|
作者
Bouhnik, AD
Chesney, M
Carrieri, P
Gallais, H
Moreau, J
Moatti, JP
Obadia, Y
Spire, B
机构
[1] INSERM, U379, F-13006 Marseille, France
[2] Reg Ctr Dis Control SE France, ORS PACA, Marseille, France
[3] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA
[4] Hop Conception, Marseille, France
[5] Hop Nord Marseille, Marseille, France
关键词
D O I
10.1097/00126334-200212153-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The authors tested the impact of social instability on adherence to highly active antiretroviral therapy (HAART) among patients infected with HIV through injection drug use (IDU; MANIF2000 cohort). In the study, they analyzed sociodemographic baseline characteristics to develop an indicator of social instability. Information concerning adherence to HAART was collected through questionnaires during a 2-year follow-up period. Factors associated with nonadherence were studied in two different groups: 1) patients who had stopped injection drug use (ex-IDUs) and who were not in drug maintenance programs (DMT) during the entire follow-up period, and 2) those who were still opiate dependent. Among the 210 eligible patients, 114 were classified as ex-IDUs and 96 as opiate dependent. Ex-IDUs reported nonadherence behaviors in 96 of 384 visits (25.0%), while opiate-dependent patients were nonadherent in I I I of 308 visits (36.0%; p = .02). Among ex-IDUs, the only factor associated with nonadherence was social instability, while among opiate-dependent patients, injection behavior was the only determinant of nonadherence behavior. For opiate-dependent patients, DMT may enhance adherence to HAART, but only if it is successful in reducing abuse of injection practices. For ex-IDUs, it is very important that the management of social difficulties be taken into account to increase adherence to HAART.
引用
收藏
页码:S149 / S153
页数:5
相关论文
共 50 条
  • [1] Drug injection cessation among HIV-infected injecting drug users
    Bouhnik, AD
    Carrieri, MP
    Rey, D
    Spire, B
    Gastaut, JA
    Gallais, H
    Obadia, Y
    [J]. ADDICTIVE BEHAVIORS, 2004, 29 (06) : 1189 - 1197
  • [2] Serial position effects in HIV-infected injecting drug users
    Waldrop, D
    Ownby, RL
    Kumar, M
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2004, 114 (04) : 493 - 516
  • [3] Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug users
    Mann, B.
    Milloy, M-J
    Kerr, T.
    Zhang, R.
    Montaner, J.
    Wood, E.
    [J]. HIV MEDICINE, 2012, 13 (10) : 596 - 601
  • [4] Quality of life of HIV-infected injecting drug users in the era of HAART
    Surah, S.
    McLaughlin, J.
    Synott, C.
    Lee, S.
    Storeng, C.
    Keating, S.
    O'Dea, S.
    Adams, R.
    Keenan, E.
    Barry, M.
    Mulcahy, F.
    Walsh, C.
    Lyons, F.
    [J]. HIV MEDICINE, 2014, 15 : 66 - 66
  • [5] Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy
    Tang, AM
    Smit, E
    Semba, RD
    Shah, N
    Lyles, CM
    Li, DG
    Vlahov, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (04): : 321 - 326
  • [6] Protease inhibitors in HIV-infected injecting drug users in Amsterdam: cumulative incidence, determinants and impact
    Schinkel, J
    Coutinho, RA
    van Ameijden, EJ
    [J]. AIDS, 1998, 12 (10) : 1247 - 1249
  • [7] Effect of cessation of drug misuse on the immune status of HIV-infected injecting drug users
    Radkowski, M
    Werezynska, T
    Laskus, T
    Kaminska, E
    Kuligowski, S
    [J]. ADDICTION BIOLOGY, 1997, 2 (01) : 95 - 99
  • [8] Can we reduce the burden of morbidity in HIV-infected injecting drug users?
    Selwyn, PA
    [J]. AIDS, 1996, 10 (12) : 1429 - 1430
  • [9] Inflammatory and immune mediators in crevicular fluid from HIV-infected injecting drug users
    Grbic, JT
    Lamster, IB
    MitchellLewis, D
    [J]. JOURNAL OF PERIODONTOLOGY, 1997, 68 (03) : 249 - 255
  • [10] Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users
    Carrieri, MP
    Rey, D
    Loundou, A
    Lepeu, G
    Sobel, A
    Obadia, Y
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2003, 72 (01) : 13 - 21